188 related articles for article (PubMed ID: 9417985)
1. Expression, purification, and crystallization of the catalytic domain of protein tyrosine phosphatase SHP-1.
Liang X; Meng W; Niu T; Zhao Z; Zhou GW
J Struct Biol; 1997 Nov; 120(2):201-3. PubMed ID: 9417985
[TBL] [Abstract][Full Text] [Related]
2. Purification and crystallization of the catalytic domain of human protein tyrosine phosphatase 1B expressed in Escherichia coli.
Barford D; Keller JC; Flint AJ; Tonks NK
J Mol Biol; 1994 Jun; 239(5):726-30. PubMed ID: 8014992
[TBL] [Abstract][Full Text] [Related]
3. Spatial constraints on the recognition of phosphoproteins by the tandem SH2 domains of the phosphatase SH-PTP2.
Eck MJ; Pluskey S; Trüb T; Harrison SC; Shoelson SE
Nature; 1996 Jan; 379(6562):277-80. PubMed ID: 8538796
[TBL] [Abstract][Full Text] [Related]
4. Specificity of the SH2 domains of SHP-1 in the interaction with the immunoreceptor tyrosine-based inhibitory motif-bearing receptor gp49B.
Wang LL; Blasioli J; Plas DR; Thomas ML; Yokoyama WM
J Immunol; 1999 Feb; 162(3):1318-23. PubMed ID: 9973385
[TBL] [Abstract][Full Text] [Related]
5. Oxidation sensitivity of the catalytic cysteine of the protein-tyrosine phosphatases SHP-1 and SHP-2.
Weibrecht I; Böhmer SA; Dagnell M; Kappert K; Ostman A; Böhmer FD
Free Radic Biol Med; 2007 Jul; 43(1):100-10. PubMed ID: 17561098
[TBL] [Abstract][Full Text] [Related]
6. The N-terminal SH2 domain of the tyrosine phosphatase, SHP-2, is essential for Jak2-dependent signaling via the angiotensin II type AT1 receptor.
Godeny MD; Sayyah J; VonDerLinden D; Johns M; Ostrov DA; Caldwell-Busby J; Sayeski PP
Cell Signal; 2007 Mar; 19(3):600-9. PubMed ID: 17027227
[TBL] [Abstract][Full Text] [Related]
7. Regulation of B cell signal transduction by SH2-containing protein-tyrosine phosphatases.
Siminovitch KA; Neel BG
Semin Immunol; 1998 Aug; 10(4):329-47. PubMed ID: 9695189
[TBL] [Abstract][Full Text] [Related]
8. Shp-2 tyrosine phosphatase: signaling one cell or many.
Feng GS
Exp Cell Res; 1999 Nov; 253(1):47-54. PubMed ID: 10579910
[TBL] [Abstract][Full Text] [Related]
9. Differential roles of N- and C-terminal immunoreceptor tyrosine-based inhibition motifs during inhibition of cell activation by killer cell inhibitory receptors.
Bruhns P; Marchetti P; Fridman WH; Vivier E; Daëron M
J Immunol; 1999 Mar; 162(6):3168-75. PubMed ID: 10092767
[TBL] [Abstract][Full Text] [Related]
10. Structural and functional effects of disease-causing amino acid substitutions affecting residues Ala72 and Glu76 of the protein tyrosine phosphatase SHP-2.
Bocchinfuso G; Stella L; Martinelli S; Flex E; Carta C; Pantaleoni F; Pispisa B; Venanzi M; Tartaglia M; Palleschi A
Proteins; 2007 Mar; 66(4):963-74. PubMed ID: 17177198
[TBL] [Abstract][Full Text] [Related]
11. The specificity of the N-terminal SH2 domain of SHP-2 is modified by a single point mutation.
Huyer G; Ramachandran C
Biochemistry; 1998 Mar; 37(9):2741-7. PubMed ID: 9485424
[TBL] [Abstract][Full Text] [Related]
12. Crystallization and preliminary X-ray analysis of the low molecular weight phosphotyrosyl protein phosphatase from bovine heart.
Zhang M; Van Etten RL; Lawrence CM; Stauffacher CV
J Mol Biol; 1994 Apr; 238(2):281-3. PubMed ID: 8158654
[TBL] [Abstract][Full Text] [Related]
13. Crystallization and preliminary X-ray diffraction studies on recombinant isopenicillin N synthase from Aspergillus nidulans.
Roach PL; Schofield CJ; Baldwin JE; Clifton IJ; Hajdu J
Protein Sci; 1995 May; 4(5):1007-9. PubMed ID: 7663335
[TBL] [Abstract][Full Text] [Related]
14. Expression, purification and X-ray characterization of residues 18-230 from the pneumococcal histidine triad protein A (PhtA) from Streptococcus pneumoniae.
Riboldi-Tunnicliffe A; Bent CJ; Isaacs NW; Mitchell TJ
Acta Crystallogr D Biol Crystallogr; 2004 May; 60(Pt 5):926-8. PubMed ID: 15103141
[TBL] [Abstract][Full Text] [Related]
15. Molecular dynamics simulations on the free and complexed N-terminal SH2 domain of SHP-2.
Wieligmann K; Pineda De Castro LF; Zacharias M
In Silico Biol; 2002; 2(3):305-11. PubMed ID: 12542415
[TBL] [Abstract][Full Text] [Related]
16. The SHP-2 tyrosine phosphatase: signaling mechanisms and biological functions.
Qu CK
Cell Res; 2000 Dec; 10(4):279-88. PubMed ID: 11191350
[TBL] [Abstract][Full Text] [Related]
17. A SHPing tale: perspectives on the regulation of SHP-1 and SHP-2 tyrosine phosphatases by the C-terminal tail.
Poole AW; Jones ML
Cell Signal; 2005 Nov; 17(11):1323-32. PubMed ID: 16084691
[TBL] [Abstract][Full Text] [Related]
18. Crystallization and preliminary X-ray analysis of Streptococcus pneumoniae hyaluronate lyase.
Jedrzejas MJ; Chantalat L; Mewbourne RB
J Struct Biol; 1998 Jan; 121(1):73-5. PubMed ID: 9573623
[TBL] [Abstract][Full Text] [Related]
19. Phosphopeptide ligands of the SHP-1 N-SH2 domain: effects on binding and stimulation of phosphatase activity.
Hampel K; Kaufhold I; Zacharias M; Böhmer FD; Imhof D
ChemMedChem; 2006 Aug; 1(8):869-77. PubMed ID: 16902940
[TBL] [Abstract][Full Text] [Related]
20. Construction and expression of an enzymatically active form of PECAM-1 containing the phosphatase domain of the protein tyrosine phosphatase, SHP-2.
Noda M; Paddock C; Newman PJ
Protein Expr Purif; 2001 Jun; 22(1):113-9. PubMed ID: 11388808
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
